7205US β2 Glyco-A (FDA cleared)
Intended Use:
AESKULISA ß2 Glyco-A is a solid phase enzyme immunoassay for the quantitative and qualitative detection of IgA antibodies against ß2 glycoprotein I in human serum.
Recombinant Antigens:
n.a.
Native Antigens:
ß2-Glycoprotein I
Published in
Thrombosis (FDA cleared Products)
Tagged under
) in the interactive HELIOS picture to activate detailed information regarding the serveral HELIOS features.